Melatonin protects against Cyclophosphamide-induced Hepatic and Renal alterations in Rats.
Keywords:
Cyclophosphamide, melatonin, liver and kidney toxicityAbstract
Cyclophosphamide (CLP), a cytotoxic alkylating agent with immunosuppressive and antitumor properties is used in the treatment of different types of cancers, but it is known to cause toxicity-induced changes to the body tissues. Melatonin an antioxidant mainly secreted by the pineal gland has protective properties especially against toxicity. This study was aimed at investigating the role of melatonin (MLT) in cyclophosphamide-induced toxicity of the liver and kidney using serum biochemical analysis and histopathology in adult Wistar rats. Twenty-four adult male Wistar rats were grouped into four (n=6): group 1 was injected intraperitoneally with 0.2mL of normal saline for 14 days, group 2 was injected with 10mg/kg of melatonin intraperitoneally for 14 days, group 3 was injected intraperitoneally with 0.2mL of normal saline for 14 days and 150mg/kg of CLP on the 15th day and in group 4, the rats were injected with 10mg/kg of melatonin for 14 days and 150mg/kg of CLP on the 15th day. Forty-eight hours after the last treatment, the rats were weighed; blood samples collected for biochemical analysis while liver and kidney samples were processed for histology. The results revealed that CLP-treated rats had hypokalemia and hypochloremia with a significant increase in the levels of liver and kidney function markers. Histopathological analysis showed congested central vein and widened sinusoids in the liver, while there were widened as well as congested urinary spaces and loop of Henle, with loss of glomerular epithelia in the kidneys. The rats treated with melatonin and CLP showed improvement in their body weight, biochemical parameters of hepatic and renal functions as well as improved tissue conditions. In conclusion, a pre-treatment with melatonin is recommended in cyclophosphamide therapy.
References
Abdel-Hafez SMN, Rifaai RA, Abdelzaher WY. 2017. Possible protective effect of royal jelly against cyclophosphamide induced prostatic damage in male albino rats; a biochemical histological and immune-histo-chemical study. Biomed Pharmacotherapy 90
Adikwu E and Bokolo B. 2018. Effect of cimetidine on cyclophosphamide-induced liver toxicity in albino rats. Asian J Med Sci, 9(5): 50-56. doi:10.3126/ajms.v9i5.19910
Arendt J, Skene DJ, Middleton B, Lockley SW and Deacon S. 1997. Efficacy of melatonin treatment in jet lag, shift work, and blindness. J Biol Rhythms, 12(6): 604-17.
Bernatsky S and Clarke AE. 2008. Ramsey-Goldman R. Cancer in systemic lupus: what drives the risk? Cancer Causes Control CCC, 19(10): 1413–1414
Bhatia AL, Manda K and Patni Sharma AL. 2006. Prophylactic action of lin-seed (Linumusitatissimum) oil against cyclophosphamide induced oxidative stress on mouse brain. J Med Food, 9: 261–964.
Bohnenstengel F, Friedel G, Rilter CA, Mc Cuellan M, Fritz P, Eicheibaum M. 2000. Variability of cyclophosphamide up-take into human bronchial carcinoma: consequences for local bio activation. Cancer Chemother Pharmacol, 45: 63–68.
Christina A. 2008. Mini review. How chemotherapy damages the central nervous system. J Biol 7: 11.
Doshi SM, Shah P, Lei X, Lahoti A, and Salahudeen AK. 2012. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis, 59: 222-228.
El-Naggar SA, Alm-Eldeen AA, Germoush MO, El-Boray KF and Elgebaly HA. 2015. Ameliorative effect of propolis against cyclophosphamide-induced toxicity in mice. Pharm Biol, 53(2): 235-241, DOI:10.3109/13880209.2014.914230
Garber J, Barbee R, Bielitzki J, Clayton L, Donovan J, Hendriksen C, et al. 2011. Guide for the care and use of laboratory animals. Washington, D.C.: Institute for Laboratory Animal Research.
Hanaa AS, Amal O, Hassan AM and Nadia AF. 2010. Effect of cyclophosphamide on transcription of SOD1 mRNA and GPX1 mRNA in mice liver and brain tissues. J Appl Biosci, 29: 1736–1742.
Hardeland R, Balzer I and Poeggeler B. 1995. On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals*. J Pineal Res, 18(2): 104-11.
Hardeland R. 2005. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine, 27: 119–130.
Kanno TN, Sensiate LA, de Paula NA and Sparça Salles MJ. 2009. Toxic effects of different doses of cyclophosphamide on the reproductive parameters of male mice. Bra Jour Pharm Sci, 45(2): 314-319.
Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, and Gillin JC. 1990. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res, 33(2): 129-34.
Li F, Patterson AD, Höfer CC, Krausz KW, Gonzalez FJ and Idle JR. 2010. Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochem Pharmacol, 80(7): 1063-1074.
McWilliam A and Macnab R. 2009. Laboratory tests of renal function. Anaesth Intensiv Care Med, 10(6): 296- 99.
Meyer D and Harvey J. 1998. Veterinary Laboratory Medicine: Interpretation and Diagnosis, 2nd edition. Philadelphia: WB Saunders Co.
Napolitano J and Singh KK. 2002. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med, 4(9): 1-19.
Ola-Davies OE, Olukole SG and Amoo OA. 2014. Haematological and Serum Biochemical Variables in rats Treated with Ethanol Extract of the Root of Moringa oleifera. Afr J Biomed Res, 17: 31-35
Olukole SG, Ajani SO, Ola-Davies OE, Lanipekun DO, Aina OO, Oyeyemi MO and Oke BO. 2018. Melatonin ameliorates bisphenol A-induced perturbations of the prostate gland of adult Wistar rats. Biomed Pharmacotherapy, 105: 73–82
Rather MA, Bilal AD, Shahnawaz NS, Bilal AB and Mushtaq AQ. 2016. Foeniculum vulgare: a comprehensive review of its traditional use, phytochemistry, pharmacology, and safety. Arab J Chem, 9(2): 1574-1583 http://dx.doi.org/10.1016/j.arabjc.2012.04.011
Rocha CS, Rato L, Martins AD, Alves MG and Oliveira PF. 2015. Melatonin and Male Reproductive Health: Relevance of Darkness and Antioxidant Properties. Curr Mol Med, 15: 1-13
Sacher RA and McPherson RA. 2000. Widmann’s clinical interpretation of laboratory tests. FA Davis Company. Washington, D. C. 1090p.
Sakr S, Shalaby S and Beder R. 2017. Ameliorative effect of fennel oil on cyclophosphamide induced hepatotoxicity in albino rats. BJPR, 17(2): 1-12.
Salahudeen AK, Ali N, George M, Lahoti A and Palla S. 2014. Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety. Cancer, 120: 744–751.
Selvakumar E, Prahalathan C, Mythili Y and Varalakshmi P. 2005. Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL-a-lipoic acid. Mol Cell Biochem, 272(1-2): 179–185.
Shajani-Yi Z, Lee HK and Cervinski MA. 2016. Hyponatremia, Hypokalemia, Hypochloremia, and Other Abnormalities. Clin Chem, 62(6): 898–898. doi:10.1373/clinchem.2015.249292
Shokrzadeh M, Ahmadi A, Naghshvar F, Chabra A and Jafarinejhad M. 2014. Prophylactic efficacy of melatonin on cyclophosphamide-induced liver toxicity in mice. BioMed Res Int, 2014: 470425. https://doi.org/10.1155/2014/470425
Stankiewicz A, Skrzydlewska E and Makieła M. 2002. Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol. Drug Interact, 19(2): 67-82.
Turk G, Ceribasi AO, Sakin F, Sonmez M and Atessahin A. 2010. Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide induced testicular lipid peroxidation and apoptosis. Reprod Fert Develop, 22(4): 587-596.
Turner TT and Lysiak JJ. 2008. Oxidative stress: A common factor in testicular dysfunction. J Androl, 29(5): 488–498. https://doi.org/10.2164/jandrol.108.005132
Published
Issue
Section
License
Copyright (c) 2020 African Journal of Biomedical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
